J9230 Mechlorethamine hcl injection
Also known as: mechlorethamine, Mustargen
Intravenous injection of mechlorethamine hydrochloride, a nitrogen mustard alkylating agent.
In Plain Language
DNA-damaging cancer drug; Hodgkin lymphoma treatment
Clinical Context
Used for Hodgkin lymphoma and other lymphomas as component of combination regimens.
RVU Information
CPT J9230 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9230?
CPT J9230 (Mechlorethamine hcl injection) is a J Codes (Drugs) code. Intravenous injection of mechlorethamine hydrochloride, a nitrogen mustard alkylating agent.
How is J9230 administered?
CPT J9230 is administered by a healthcare provider, typically via injection or infusion. Used for Hodgkin lymphoma and other lymphomas as component of combination regimens. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9230 used?
Used for Hodgkin lymphoma and other lymphomas as component of combination regimens.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.